Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave s Revenues, Net Loss Up in Q4

NEW YORK, Feb. 24 (GenomeWeb News) - Third Wave Technologies today reported increased revenues as well as losses for the fourth quarter of 2003.

 

Revenues totaled $9.7 million, up from $7.6 million during the same period a year ago.

 

R&D expenses for the quarter were $3.8 million, slightly up from $3.3 million during the year-ago period. 

 

Third Wave recorded a net loss of $1.6 million, or $.04 per share, for the quarter, compared to $.5 million, or $.01 per share, during the same period in 2002.

 

As of Dec. 31, the company had cash, cash equivalents, and short-term investments of $57.8 million.

 

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.